FTSE All-Share
5.479,78
PKT
-90,59
PKT
-1,63
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.06.17 | GSK Neutral | UBS AG | |
| 09.06.17 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 09.06.17 | HSBC Neutral | Goldman Sachs Group Inc. | |
| 09.06.17 | Barclays Sell | Goldman Sachs Group Inc. | |
| 09.06.17 | BT Group Outperform | Bernstein Research | |
| 09.06.17 | BT Group Sell | Deutsche Bank AG | |
| 08.06.17 | BT Group Neutral | JP Morgan Chase & Co. | |
| 08.06.17 | BP buy | Deutsche Bank AG | |
| 08.06.17 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 08.06.17 | BP buy | UBS AG | |
| 08.06.17 | Rio Tinto buy | Jefferies & Company Inc. | |
| 08.06.17 | National Grid Sell | Deutsche Bank AG | |
| 07.06.17 | Unilever Neutral | UBS AG | |
| 07.06.17 | Unilever Neutral | UBS AG | |
| 07.06.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 07.06.17 | HSBC Hold | Deutsche Bank AG | |
| 07.06.17 | Barclays buy | UBS AG | |
| 06.06.17 | Lloyds Banking Group Sell | Goldman Sachs Group Inc. | |
| 06.06.17 | BP buy | UBS AG | |
| 06.06.17 | Sky buy | UBS AG | |
| 06.06.17 | AstraZeneca overweight | Morgan Stanley | |
| 06.06.17 | Prudential buy | Goldman Sachs Group Inc. | |
| 06.06.17 | AstraZeneca Reduce | HSBC | |
| 06.06.17 | GSK Strong Sell | S&P Capital IQ | |
| 02.06.17 | London Stock Exchange (LSE) Neutral | UBS AG | |
| 01.06.17 | Barclays overweight | JP Morgan Chase & Co. | |
| 01.06.17 | Lloyds Banking Group overweight | JP Morgan Chase & Co. | |
| 01.06.17 | Glencore buy | Jefferies & Company Inc. | |
| 31.05.17 | Diageo market-perform | Bernstein Research | |
| 31.05.17 | GSK buy | Goldman Sachs Group Inc. | |
| 31.05.17 | London Stock Exchange (LSE) buy | Commerzbank AG | |
| 31.05.17 | Diageo Outperform | Credit Suisse Group | |
| 31.05.17 | GSK Hold | Deutsche Bank AG | |
| 31.05.17 | BT Group Hold | Jefferies & Company Inc. | |
| 31.05.17 | London Stock Exchange (LSE) Neutral | JP Morgan Chase & Co. | |
| 31.05.17 | GSK Neutral | JP Morgan Chase & Co. | |
| 30.05.17 | Lloyds Banking Group buy | Deutsche Bank AG | |
| 30.05.17 | London Stock Exchange (LSE) Neutral | UBS AG | |
| 30.05.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.05.17 | Vodafone Group Outperform | Bernstein Research |